Skip to content
Allucent
  • ENGLISH
  • FRANCAIS
  • Services
    • Services Overview
    • Clinical Trial Operations
      • Protocol Development and Study Design
      • Feasibility and Study Start Up
      • Patient Recruitment
      • Project Management
      • Clinical Operations
      • Centralized Monitoring
      • Decentralized Clinical Trials (DCT)
      • Centralized eTMF
      • Medical Services
    • Regulatory and Drug Development Consulting
      • Clinical Strategy
      • Nonclinical
      • Chemistry, Manufacturing, and Controls (CMC)
      • Regulatory Affairs
      • GxP Strategy Consulting
      • Publishing and Submissions
      • Medical Writing
    • Government and Public Health Services
    • Biometrics
      • Biostatistics and Statistical Programming
      • Data Management
    • Clinical Pharmacology Modeling Simulation
      • Clinical Pharmacology Integrated Drug Development
      • Model Informed Dose & Drug Development (MIDD)
      • Pharmacometrics (PMx), Pharmacokinetics, Pharmacodynamics (PK/PD)
      • DMPK and Translational Discovery and Development
  • Therapeutic Expertise
    • Therapeutic Expertise Overview
    • By Subject
      • Oncology and Hematology
      • Rare Diseases and Orphan Drugs
      • Infectious Disease and Vaccine
      • Cell and Gene Therapy
      • Central Nervous System
      • Autoimmune and Inflammation
      • Allergy and Asthma
    • By Phase
  • Company
    • About Us
    • History
    • News
    • Events
    • Leadership Team
    • Mission, Vision, Values
  • Resources
    • Resource Library
    • Blogs
    • Case Studies
    • Podcasts
    • Webinar
    • White Paper
  • Careers
    • Careers Overview
    • Job Listings
    • CRA Academy and Fellows Programs
  • Contact Us
    • Contact Us
    • Request for Proposal / Information
Menu
  • Services
    • Services Overview
    • Clinical Trial Operations
      • Protocol Development and Study Design
      • Feasibility and Study Start Up
      • Patient Recruitment
      • Project Management
      • Clinical Operations
      • Centralized Monitoring
      • Decentralized Clinical Trials (DCT)
      • Centralized eTMF
      • Medical Services
    • Regulatory and Drug Development Consulting
      • Clinical Strategy
      • Nonclinical
      • Chemistry, Manufacturing, and Controls (CMC)
      • Regulatory Affairs
      • GxP Strategy Consulting
      • Publishing and Submissions
      • Medical Writing
    • Government and Public Health Services
    • Biometrics
      • Biostatistics and Statistical Programming
      • Data Management
    • Clinical Pharmacology Modeling Simulation
      • Clinical Pharmacology Integrated Drug Development
      • Model Informed Dose & Drug Development (MIDD)
      • Pharmacometrics (PMx), Pharmacokinetics, Pharmacodynamics (PK/PD)
      • DMPK and Translational Discovery and Development
  • Therapeutic Expertise
    • Therapeutic Expertise Overview
    • By Subject
      • Oncology and Hematology
      • Rare Diseases and Orphan Drugs
      • Infectious Disease and Vaccine
      • Cell and Gene Therapy
      • Central Nervous System
      • Autoimmune and Inflammation
      • Allergy and Asthma
    • By Phase
  • Company
    • About Us
    • History
    • News
    • Events
    • Leadership Team
    • Mission, Vision, Values
  • Resources
    • Resource Library
    • Blogs
    • Case Studies
    • Podcasts
    • Webinar
    • White Paper
  • Careers
    • Careers Overview
    • Job Listings
    • CRA Academy and Fellows Programs
  • Contact Us
    • Contact Us
    • Request for Proposal / Information

Tag: PB/PK

Efficient Clinical Programs and Decision Making Through Model-Informed Drug Development (MIDD)

Efficient Clinical Programs and Decision Making Through Model-Informed Drug Development (MIDD) Join Alex MacDonald, VP Model-Informed Drug Development, on how MIDD can help your clinical trials.

Services​
  • Clinical Trial Operations
  • Regulatory and Drug Development Consulting
  • Government and Public Health Services
  • Biometrics
  • Clinical Pharmacology Modeling Simulation
  • Clinical Trial Operations
  • Regulatory and Drug Development Consulting
  • Government and Public Health Services
  • Biometrics
  • Clinical Pharmacology Modeling Simulation
Therapeutic Expertise
  • Oncology and Hematology
  • Rare Diseases and Orphan Drugs
  • Infectious Disease and Vaccine
  • Cell and Gene Therapy
  • Central Nervous System
  • Autoimmune and Inflammation
  • Allergy and Asthma
  • Oncology and Hematology
  • Rare Diseases and Orphan Drugs
  • Infectious Disease and Vaccine
  • Cell and Gene Therapy
  • Central Nervous System
  • Autoimmune and Inflammation
  • Allergy and Asthma
Company
  • About Us
  • News
  • Events
  • About Us
  • News
  • Events
Linkedin-in Youtube
  • Privacy Policy
  • English
  • Francais

© 2023 Allucent. All rights

Allucent
North American Headquarters

2000 Centregreen Way
Suite 300
Cary, North Carolina 27513
+1 919-361-2286

United Kingdom Headquarters

1st Floor, One Station Square,
Bracknell, Berkshire
RG12 1QB United Kingdom
T: +44 (0) 1344 891121
F: +44 (0) 1344 890335

European Headquarters

Stationsplein Noord-Oost 438
1117 CL Schiphol
The Netherlands
+31 20-4350-580